Testosterone treatment and cardiovascular events in prescription database studies
- PMID: 28816202
- PMCID: PMC5858096
- DOI: 10.4103/aja.aja_25_17
Testosterone treatment and cardiovascular events in prescription database studies
Abstract
Over the past decade, there has been a substantial increase in the number of men who are treated with testosterone. Despite this increase in the use of testosterone, the risks of adverse cardiovascular events are unclear as meta-analyses have reported conflicting findings and no clinical studies have been large enough or long enough to adequately assess for cardiovascular risks. The goal of this paper is to review large prescription database studies of testosterone treatment and adverse cardiovascular events and mortality with the aim of providing some guidance for clinicians and researchers in this controversial area.
Keywords: cardiovascular diseases; cohort studies; myocardial infarction; stroke; testosterone/adverse effects; thrombosis.
References
-
- Yeap BB, Chubb SA, Hyde Z, Jamrozik K, Hankey GJ, et al. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur J Endocrinol. 2009;161:591–8. - PubMed
-
- Isidori AM, Giannetta E, Pozza C, Bonifacio V, Isidori A. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest. 2005;28:73–9. - PubMed
-
- Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166:1660–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
